Cash Flow from Operating Activities: A company's cash flows from operations.
Thermo Fisher Scientific Inc. (TMO) had Cash Flow from Operating Activities of $1.19B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$11.01B |
|
$1.65B |
|
$6.53B |
|
$4.48B |
|
$9.14B |
|
$1.86B |
|
$-130.00M |
|
$1.73B |
|
$1.73B |
|
$1.66B |
|
$1.66B |
|
$1.66B |
|
$1.66B |
|
$1.86B |
|
-- |
|
372.00M |
|
373.00M |
|
$4.44 |
|
$4.43 |
|
| Balance Sheet Financials | |
$22.32B |
|
$10.66B |
|
$90.96B |
|
$113.28B |
|
$14.62B |
|
$40.07B |
|
$46.72B |
|
$61.34B |
|
-- |
|
$-22.39B |
|
$51.94B |
|
-- |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$1.19B |
$-8.96B |
|
$1.09B |
|
$9.88B |
|
$3.28B |
|
$-6.60B |
|
-- |
|
$-162.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|